Good morning :)
$
₹
DexCom Inc

DexCom Inc

DXCM

NASDAQ
Asset Logo

DexCom Inc

DXCM

NASDAQ
$87.805.82% (+4.83)
$
₹
$87.805.82% (+4.83)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $31.6B the stock is ranked 466

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

33.37
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

12.10
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$2.54
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.36
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

19.42%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 29 analysts reports

Buy
26 analysts
Hold
3 analysts
Sell
0 analyst

Price Upside

+15.8%

Earnings Growth

+29.18%

Rev. Growth

+12.14%

See Detailed Forecast

Company Profile

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
40.95
40.95
1Y Return
11.04%
11.04%
Buy Reco %
82.14
82.14
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.74
37.74
1Y Return
6.49%
6.49%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
52.82
52.82
1Y Return
19.01%
19.01%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
23.69
23.69
1Y Return
9.62%
9.62%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
32.67
32.67
1Y Return
13.29%
13.29%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 15.80% growth, versus a trailing 3-year CAGR of -4.55%.

2026
Current$84.76Baseline
Analyst Target - 1 year
Target$98.15+15.8%

All values in $

202220232024202520262027$78.92$98.12$117.31Target+15.8%
2026
Current$84.76Baseline
Analyst Target - 1 year
Target$98.15+15.8%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 12.14% growth, versus a trailing 3-year CAGR of 17.01%.

2025
Current$4.66Baseline
Forecast for Dec 2026
High$5.24+12.56%
Average$5.22+12.14%
Low$5.20+11.68%

All values in $ Billion

2021202220232024202520262.442.903.624.034.66Low+11.68%Average+12.14%High+12.56%
2025
Current$4.66Baseline
Forecast for Dec 2026
High$5.24+12.56%
Average$5.22+12.14%
Low$5.20+11.68%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 29.18% growth, versus a trailing 3-year CAGR of 33.93%.

2025
Current$2.09Baseline
Forecast for Dec 2026
High$2.78+33.01%
Average$2.7+29.18%
Low$2.45+17.22%

All values in $

2021202220232024202520260.660.871.511.652.09Low+17.22%Average+29.18%High+33.01%
2025
Current$2.09Baseline
Forecast for Dec 2026
High$2.78+33.01%
Average$2.7+29.18%
Low$2.45+17.22%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

1.2
0.2
1.1
0.1
1.3
0.2
1.3
0.2
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue10.991.111.031.151.201.251.191.301.34
Net Income0.140.130.150.100.170.280.260.190.240.27
Net Profit Margin14.28%13.53%13.62%10.17%15.53%23.46%21.22%16.73%19.03%20.46%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
DexCom Inc 33.3712.101.36
Abbott Laboratories40.953.591.51
Danaher Corporation37.743.041.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare DXCM with any stock or ETF
Compare DXCM with any stock or ETF
Comparing from
DXCM
ABT
DHR
Loading...

Frequently asked questions

  1. DexCom Inc (DXCM) share price today is $87.80 as of November 5, 2026 at 1:21 AM IST. The stock touched a day high of $88.90 and a day low of $85.17.

  2. DexCom Inc stock trades on NASDAQ under the ticker symbol DXCM.

  3. DexCom Inc's market capitalization is $31.61B as of November 5, 2026 at 1:21 AM IST.

  4. DexCom Inc's price-to-earnings (P/E) ratio is 33.37 as of November 4, 2026.

  5. DexCom Inc's price-to-book (P/B) ratio is 12.10 as of November 4, 2026.

  6. Yes, You can buy DexCom Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy DexCom Inc shares in three steps: 1. Search DexCom Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since DexCom Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in DexCom Inc (DXCM) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1138 shares at the current price of $87.80.

Loading...